Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Cash from Financing Activities (2020 - 2026)

Opus Genetics has reported Cash from Financing Activities over the past 10 years, most recently at $27.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 34.84% to $27.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $57.2 million through Mar 2026, up 156.58% year-over-year, with the annual reading at $50.0 million for FY2025, 1095.01% up from the prior year.
  • Cash from Financing Activities was $27.6 million for Q1 2026 at Opus Genetics, up from $24.1 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $27.6 million in Q1 2026 and troughed at -$83000.0 in Q4 2024.
  • The 5-year median for Cash from Financing Activities is $1.6 million (2022), against an average of $6.3 million.
  • Year-over-year, Cash from Financing Activities surged 30125.0% in 2023 and then tumbled 102.3% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$12000.0 in 2022, then surged by 30125.0% to $3.6 million in 2023, then crashed by 102.3% to -$83000.0 in 2024, then surged by 29146.99% to $24.1 million in 2025, then increased by 14.46% to $27.6 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Cash from Financing Activities are $27.6 million (Q1 2026), $24.1 million (Q4 2025), and $4.5 million (Q3 2025).